FDA Approves Novel Drug (Vimseltinib) for Rare Joint Tumour: A New Frontier in Targeted Therapy
I. Vimseltinib The Food and Drug Administration (FDA) has recently (14 Feb, 2025) approved Vimseltinib (Romvimza), a groundbreaking targeted…
New Research: Can Yogurt & Calcium Lower Bowel Cancer Risk ?
Recent findings from two robust, peer-reviewed studies are offering promising insights into how everyday dietary choices—specifically yogurt and calcium-rich…